Schedule 13D ownership disclosure

ARIAD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 04033A100

Event date: 2017-02-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-17-000284
Form type
SC 13D/A
Filer
ARIAD PHARMACEUTICALS INC
CIK
CIK 884731
Filed
Feb 21, 2017
Reporting period
Feb 16, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub